FDA Drug recall D-0998-2020
Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834
- FDA Drug
- Class II
- terminated
- Published 2020-03-18
On 2020-03-18 the FDA classified a Class II recall of Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834 by Mayne Pharma, citing product Mix-Up: A foreign tablet was found in bottle.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0998-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-03-02 |
| Published | 2020-03-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Mayne Pharma |
| Distribution | US |
Product
Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01
Reason
Product Mix-Up: A foreign tablet was found in bottle.
Identifiers
| code_info | Lot: FG11514 Exp. 05/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0998-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.